These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 2659055)

  • 21. Effective plasma volume in cirrhosis with ascites. Evidence that a decreased value does not account for renal sodium retention, a sponteneous reduction in glomerular filtration rate (GFR), and a fall in GFR during drug-induced diuresis.
    Lieberman FL; Ito S; Reynolds TB
    J Clin Invest; 1969 Jun; 48(6):975-81. PubMed ID: 5771197
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cirrhotic ascites: pathogenesis and management.
    Garcia-Tsao G
    Gastroenterologist; 1995 Mar; 3(1):41-54. PubMed ID: 7743121
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pathogenetic factors and clinical elements in ascites and hepatorenal syndrome during liver cirrhosis.
    Gentilini P; Laffi G; La Villa G; Raggi VC
    Ann Ital Med Int; 1999; 14(4):264-84. PubMed ID: 10638019
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Refractory ascites: pathogenesis, definition and therapy of a severe complication in patients with cirrhosis.
    Salerno F; Guevara M; Bernardi M; Moreau R; Wong F; Angeli P; Garcia-Tsao G; Lee SS
    Liver Int; 2010 Aug; 30(7):937-47. PubMed ID: 20492521
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Management of ascites in cirrhosis.
    Sandhu BS; Sanyal AJ
    Clin Liver Dis; 2005 Nov; 9(4):715-32, viii. PubMed ID: 16207572
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Abnormal sympathetic and renal response to sodium restriction in compensated cirrhosis.
    Simón MA; Díez J; Prieto J
    Gastroenterology; 1991 Nov; 101(5):1354-60. PubMed ID: 1936807
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pathogenesis of ascites in cirrhosis and portal hypertension.
    Heneghan MA; Harrison PM
    Med Sci Monit; 2000; 6(4):807-16. PubMed ID: 11208415
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [The renin-angiotensin-aldosterone system in liver cirrhosis].
    Giudici Cipriani A; Folco U; Colombo P; Menardo G; Cattana A; Barbetti V; Rembado R; Marenco G
    Minerva Med; 1990; 81(1-2):45-53. PubMed ID: 2314615
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ascites in liver diseases.
    Gentilini P; Laffi G
    Ann Ital Med Int; 1991; 6(1 Pt 2):148-55. PubMed ID: 1742150
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Fluid retention in cirrhosis: pathophysiology and management.
    Kashani A; Landaverde C; Medici V; Rossaro L
    QJM; 2008 Feb; 101(2):71-85. PubMed ID: 18184668
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Splanchnic circulatory and tissue fluid dynamics in portal hypertension.
    Witte CL; Witte MH
    Fed Proc; 1983 Apr; 42(6):1685-9. PubMed ID: 6832387
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ascites and hepatorenal syndrome: pathogenesis and treatment strategies.
    Ginès P; Arroyo V; Rodés J
    Adv Intern Med; 1998; 43():99-142. PubMed ID: 9506180
    [No Abstract]   [Full Text] [Related]  

  • 33. An update on the pathogenesis and clinical management of cirrhosis with refractory ascites.
    Neong SF; Adebayo D; Wong F
    Expert Rev Gastroenterol Hepatol; 2019 Apr; 13(4):293-305. PubMed ID: 30791777
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sodium retention and ascites formation in dogs with experimental portal cirrhosis.
    Levy M
    Am J Physiol; 1977 Dec; 233(6):F572-85. PubMed ID: 596455
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Gut microflora in the pathogenesis of the complications of cirrhosis.
    Garcia-Tsao G; Wiest R
    Best Pract Res Clin Gastroenterol; 2004 Apr; 18(2):353-72. PubMed ID: 15123075
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Vasopressin 1a receptor partial agonism increases sodium excretion and reduces portal hypertension and ascites in cirrhotic rats.
    Fernández-Varo G; Oró D; Cable EE; Reichenbach V; Carvajal S; de la Presa BG; Wiśniewski K; Ginés P; Harris G; Jiménez W
    Hepatology; 2016 Jan; 63(1):207-16. PubMed ID: 26403564
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ascites, refractory ascites and hyponatremia in cirrhosis.
    Fortune B; Cardenas A
    Gastroenterol Rep (Oxf); 2017 May; 5(2):104-112. PubMed ID: 28533908
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Mechanism of ascites formation and its management in liver cirrhosis].
    Suzuki K; Nakamura A; Kato A; Yoshida T; Sato S
    Nihon Rinsho; 1994 Jan; 52(1):97-103. PubMed ID: 8114318
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Reduced central blood volume in cirrhosis.
    Henriksen JH; Bendtsen F; Sørensen TI; Stadeager C; Ring-Larsen H
    Gastroenterology; 1989 Dec; 97(6):1506-13. PubMed ID: 2583416
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pathophysiology of ascites and dilutional hyponatremia: contemporary use of aquaretic agents.
    Leiva JG; Salgado JM; Estradas J; Torre A; Uribe M
    Ann Hepatol; 2007; 6(4):214-21. PubMed ID: 18007550
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.